SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: JOEBT1 who wrote (12857)12/28/1997 12:46:00 AM
From: Scusami  Respond to of 32384
 
JOEBT1:

LGND has not kept up with AGN or the AMEX BTK since early Nov. LGND has done worse and has been more volatile since that time. Perhaps the newly acquired LGND shares that went toward covering short positions (it decreased in half during the last month) are all that will be tendered. I would guess that the rest are now in stronger hands and that we should start seeing a turn around. The daily and weekly momentum charts (MACD) have bottomed according to my charting software.

Scusami



To: JOEBT1 who wrote (12857)12/28/1997 9:45:00 AM
From: tonyt  Read Replies (2) | Respond to of 32384
 
> LGND's fair market value should be $18 to $24 per share now.(IMHO)

Although Mr Market thinks otherwise, I remember a short while back when $18 was supposed to be 'undervalued'.

The real question to ask in order to determine fair value is 'at what price would you sell?' -- Since there was a lot of selling at 14-15, I would state that fair value at this time appears to be $15.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News